Outcomes in Critically Ill Patients with Cancer-Related Complications
Viviane Bogado Leite Torres(Universidade Federal do Rio de Janeiro), Márcio Soares(University of Copenhagen), Pedro Caruso, Marcos Freitas Knibel, Juliana Vassalo(Universidade Federal do Rio de Janeiro), Eliézer Silva(Erasmus Hospital), Ulysses V. A. Silva(Università Cattolica del Sacro Cuore), Jorge I. Salluh(Universidade Federal do Rio de Janeiro), Fernando A. Bozza(D’Or Institute for Research and Education), José Jorge Soares Netto(Hospital de Base), José Teles, Ederlon Rezende(Medico), Luciano C. P. Azevedo(Hospital Israelita Albert Einstein), Cláudio Piras, Nelson Spector(Universidade Federal do Rio de Janeiro), André P. Torelly(Hospital de Base)
Cited by 42
Related Papers
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
|Blood|2020|776
Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis
|Critical Care|2007|744
Characterisation of the first 250 000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data
|The Lancet Respiratory Medicine|2021|527
A Central Role for Free Heme in the Pathogenesis of Severe Sepsis
|Science Translational Medicine|2010|492